J&J to buy Alios BioPharma for $1.75 billion
September 30, 2014 at 09:23 AM EDT
Alios’ portfolio includes a treatment for infants with respiratory syncytial virus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.